The biggest medtech news of the week, in one minute or less.

MDDI Staff

July 2, 2021

2 Min Read
Medtech news
Graphic by Amanda Pedersen / MD+DI

Philips’ 3D ICE Hits Right As EP Market Heats Up

Just as the electrophysiology (EP) market is really heating up, Royal Philips has added a new 3D intracardiac echocardiography (ICE) catheter to the mix. Philips says its new real-time 3D intracardiac echocardiography (ICE) catheter has the potential to improve standard of care for structural heart disease and EP procedures. Wins CE Mark on Heels of $71M Financing’s flagship solution, Viz LVO, uses AI to automatically detect suspected large vessel occlusion (LVO) strokes on computed tomography angiography imaging and directly alert on-call stroke specialists about potentially treatable patients in a standalone or multi-hospital network. In 2018, MD+DI named as one of six AI companies set to rock the medtech world.

Medtronic Breaks Ground in Colorado

Medtronic broke ground on a 400,000 square foot Lafayette, CO innovation center and campus. The new campus is intended to unite employees from Medtronic's Boulder, CO and Louisville, CO facilities onto one campus. The company's manufacturing operations currently at the Boulder and Louisville campuses will remain there. Anticipated to be complete with staff moving in during the second half of 2022, the plan includes two five-story connected buildings, which will host 1,100 employees.

And in case you missed our last Medtech in a Minute report...

Medtronic's First Soft-Tissue Robotic Surgery Is in the Books

Medtronic said the first patient procedure performed with the Hugo robotic-assisted surgery (RAS) system was a robotic prostatectomy performed June 19 by Ruben Olivares, MD, at Clínica Santa Maria in Santiago, Chile. The procedure marks the beginning of the Hugo RAS system patient registry, which will collect clinical data to support regulatory submissions around the world.

Boston Scientific Gains a Competitive Edge in the EP Market

Boston Scientific said it will acquire the remaining shares of Farapulse, which the company inked an investment agreement with last year. Farapulse has developed a pulsed field ablation (PFA) system, which received breakthrough designation in May 2019. Farapulse already has a CE mark for the PFA system, and is currently enrolling patients in a U.S. pivotal trial. The device – comprising a sheath, generator, and catheters – is intended to ablate heart tissue via the creation of a therapeutic electric field instead of using thermal energy sources such as radiofrequency ablation or cryoablation.

Leadership Shakeup on the Horizon for Two Prominent Players

Integra Lifesciences President and CEO Peter Arduini will step down at the end of the year to take the helm at GE Healthcare. Kieran Murphy, GE Healthcare’s current president and CEO, is planning to retire from the role.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like